# Alteration in ATR protein level does not account for the inherent radiosensitivity of HPV-positive head and neck squamous cell carcinoma

**Authors:** Sibylla Kohl, Florentine S.B. Subtil, Vanessa Climenti, Houmam Anees, Ann C. Parplys, Rita Engenhart-Cabillic, Sebastian Adeberg, Ekkehard Dikomey, Ulrike Theiß

PMC · DOI: 10.1016/j.tranon.2025.102359 · 2025-03-14

## TL;DR

This study shows that lower ATR protein levels in HPV-positive head and neck cancer cells do not cause their increased sensitivity to radiation, but instead work together with radiation effects.

## Contribution

The study reveals that reduced ATR protein levels in HPV-positive cells are not responsible for their radiosensitivity but contribute additively to it.

## Key findings

- HPV-positive cells have lower ATR protein levels but maintain functional ATR activity after radiation.
- ATR knockdown increases radiosensitivity and residual DNA damage only in HPV-positive cells.
- HPV-positive cells repair DNA breaks via homologous recombination despite low ATR levels.

## Abstract

•HPV-positive HNSCC cells show lower ATR protein levels than HPV-negative.•Despite low protein levels, ATR is fully functional and activated in response to radiation.•HPV-positive but not HPV-negative cells are radiosensitized after ATR knockdown.•HPV-positive cells are able to repair one-ended DSBs by homologous recombination.

HPV-positive HNSCC cells show lower ATR protein levels than HPV-negative.

Despite low protein levels, ATR is fully functional and activated in response to radiation.

HPV-positive but not HPV-negative cells are radiosensitized after ATR knockdown.

HPV-positive cells are able to repair one-ended DSBs by homologous recombination.

Human papilloma virus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) cells are highly radiosensitive resulting from an elevated number of DNA double-strand breaks (DSB) remaining after irradiation. Partially this effect is due to a defective homologous recombination (HR). HPV-positive cells also show pronounced instability of chromosome 3, which codes for the kinase ataxia-telangiectasia and Rad3-related (ATR) protein, a central player of HR. If there is a contribution of ATR to the radiosensitivity of HPV-positive cells remains unclear, and this in-vitro study tested a functional involvement of ATR expression.

The study was performed with six HPV-negative and six HPV-positive HNSCC cell lines. Gene copy number and gene expression were determined via qRT-PCR, protein expression by Western Blot. Response of cells towards irradiation in dependence of ATR expression was tested after siRNA Knock-down (ATRKD). Clonogenic survival after photon irradiation was evaluated by colony formation assay and DSBs were visualized by γH2AX/53BP1 co-staining.

ATR gene copy number and expression were not altered. Protein level was almost two-fold lower in HPV-positive compared to HPV-negative cells, but fully functional as observed by active phosphorylation in response towards irradiation. ATRKD resulted in a further increase in both, radiosensitivity as well as number of residual DSBs, but only for HPV-positive cells.

Since the effect of ATRKD was compensated in HPV-negative but not in HPV-positive cells, these data revealed that the two-fold lower level of ATR in HPV-positive cells does not account for their enhanced inherent radiosensitivity, but acts additive to irradiation.

## Linked entities

- **Genes:** ATR (ATR checkpoint kinase) [NCBI Gene 545]
- **Proteins:** ATR (ATR checkpoint kinase)
- **Diseases:** head and neck squamous cell carcinoma (MONDO:0010150)

## Full-text entities

- **Genes:** TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}
- **Diseases:** HNSCC (MESH:D000077195)
- **Species:** Human papillomavirus (species) [taxon 10566]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11957528/full.md

---
Source: https://tomesphere.com/paper/PMC11957528